OrthoPediatrics Corp.

78 articles with OrthoPediatrics Corp.

• OrthoPediatrics Corp. Announces Launch of Next Generation Cannulated Screw System

  6/10/2021

  OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced the launch of its 6.5mm/7.3mm Slipped Capital Femoral Epiphysis Cannulated Screw system.

• OrthoPediatrics Corp. to Present at the 2021 JMP Securities Life Sciences Conference

  6/9/2021

  OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced that Dave Bailey, Chief Executive Officer, Fred Hite, Chief Operating Officer and Chief Financial Officer, and Mark Throdahl, Executive Chairman, are scheduled to participate in the 2021 JMP Securities Life Sciences Conference on Thursday, June 17, 2021.

• OrthoPediatrics Corp. Completes Senior Leadership Transition with Appointment of David Bailey as Chief Executive Officer

  6/3/2021

  OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced the completion of the senior leadership transition, with David Bailey succeeding Mark Throdahl as Chief Executive Officer.

• OrthoPediatrics Corp. Launches RESPONSE™ Neuromuscular Scoliosis System

  5/28/2021

  OrthoPediatrics Corp. (“OrthoPediatrics”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced the launch of its RESPONSE™ Neuromuscular Scoliosis System.

• OrthoPediatrics Corp. Continues Double Diamond Sponsorship for 2021 POSNA Meeting

  5/17/2021

  OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, has continued the Company’s support for the 2021 Pediatric Orthopaedic Society of North America annual meeting, held last week in Dallas, Texas.

• OrthoPediatrics Corp. Reports First Quarter 2021 Financial ResultsFirst Quarter 2021 Revenue Increased 31.2% Year-over-Year with Continued Strong Domestic Growth and Turnaround in International

  5/5/2021

  OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced its financial results for the first quarter ended March 31, 2021.

• OrthoPediatrics Corp. to Participate in the 7th Annual Truist Securities 2021 Life Sciences Summit

  4/22/2021

  OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President, Fred Hite, Chief Operating Officer and Chief Financial Officer, and Mark Throdahl, Chief Executive Officer, are scheduled to participate in a fireside chat at the 7th Annual Truist Securities 2021 Life Sciences Summit on Wednesday, May 5, 2021.

• OrthoPediatrics Corp. to Report First Quarter 2021 Financial Results on May 5, 2021Conference Call to Discuss Results on May 6, 2021 at 8:00 a.m. ET

  4/21/2021

  OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its first quarter 2021 financial results on Wednesday, May 5, 2021, after the market closes. OrthoPediatrics will host a conference call on Thursday, May 6, 2021, at 8:00 a.m. ET to discuss the results.

• OrthoPediatrics Corp. to Participate in the 20th Annual Needham Virtual Healthcare Conference

  3/31/2021

  OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced that Dave Bailey, President, Fred Hite, Chief Operating Officer and Chief Financial Officer, and Mark Throdahl, Chief Executive Officer, are scheduled to participate in a fireside chat at the 20th Annual Needham Virtual Healthcare Conference on Tuesday, April 13, 2021.

• OrthoPediatrics Surpasses Milestones of 500 Scoliosis Correction Cases Worldwide and Nine-Years of Clinical Experience with the ApiFix Procedure

  3/23/2021

  The Internal Brace Option™ is a viable alternative for treating progressive moderate scoliosis in adolescents and a game-changing treatment option for medical providers and patients to consider

• OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2020 Financial Results

  3/10/2021

  OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced its financial results for the fourth quarter and full year ended December 31, 2020.

• OrthoPediatrics Corp. Crosses Milestone Treating 200,000 Children with Orthopedic Conditions

  3/4/2021

  OrthoPediatrics Corp., a company exclusively focused on advancing the field of pediatric orthopedics, announced that as of March 2021, it estimates over 200,000 children with orthopedic conditions have been treated with OP products.

• OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2020 Financial Results on March 10, 2021Conference Call to Discuss Results on March 11, 2021 at 8:00 a.m. ET

  3/3/2021

  OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced that the Company is scheduled to release its fourth quarter and full year 2020 financial results on Wednesday, March 10, 2021, after the market closes.

• 2021 Best Places to Work in Indiana

  2/24/2021

  OrthoPediatrics Corp., a company exclusively focused on advancing the field of pediatric orthopedics, announced it was recently named as one of the 2021 Best Places to Work in Indiana.

• OrthoPediatrics Corp. Launches Dedicated ApiFix Website to Support Game-Changing Spinal Deformity Correction System for Treating AIS

  2/18/2021

  OrthoPediatrics and ApiFix are committed to helping patients with adolescent idiopathic scoliosis and their families make informed decisions about treatment options in partnership with their physiotherapist and pediatric orthopedic specialist

• OrthoPediatrics Corp. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

  2/11/2021

  OrthoPediatrics Corp. announced that Dave Bailey, President, Fred Hite, Chief Operating Officer and Chief Financial Officer, and Mark Throdahl, Chief Executive Officer, are scheduled to participate in a fireside chat at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Thursday, February 18, 2021.

• OrthoPediatrics Corp. Introduces Orthex in Australia

  1/22/2021

  OrthoPediatrics Corp., a company exclusively focused on advancing the field of pediatric orthopedics, continues to expand their product offering in Australia and New Zealand.

• OrthoPediatrics Corp. Introduces Expanded Product Portfolio in Canada

  1/19/2021

  OrthoPediatrics Corp., a company exclusively focused on advancing the field of pediatric orthopedics, has obtained 14 product registrations in Canada over the past 12 months.

• OrthoPediatrics Corp. Expands its Agent Network in Three Strategic European Countries

  1/15/2021

  OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced the expansion of its agent network in Germany, Austria and Switzerland.

• OrthoPediatrics Corp. Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2020Full year revenue up 2%, representing strong execution in an unprecedented global environment

  1/11/2021

  OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its preliminary unaudited revenue for the fourth quarter and full year ended December 31, 2020. Preliminary unaudited fourth quarter 2020 revenue is expected to be $21.7 million, up 14%, when compared to $19.0 million in the fourth quarter of 2019. Preliminary domestic revenu